Restasis and Onglyza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Onglyza (saxagliptin hydrochloride). Common drug interactions include fall among females and aggression among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Onglyza. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Onglyza?

Onglyza has active ingredients of saxagliptin hydrochloride. It is often used in diabetes. eHealthMe is studying from 8,638 Onglyza users. Check the latest studies of Onglyza.

On Jul, 13, 2026

24 people who take Restasis and Onglyza together, and have interactions are studied.

What are the common drug interactions of Restasis and Onglyza, by gender? *:

female:

Fall
Asthma
Chronic kidney disease
Anaemia (lack of blood)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Joint injury
Post-traumatic stress disorder
Renal injury (kidney injury)
Sedation

male:

Aggression
Lacunar infarction (a type of stroke)
Death
Disturbance in attention
Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Headache (pain in head)
Heart rate increased
Lip oedema (swelling of lip)
Pancreatic carcinoma (pancreatic cancer)

What are the common drug interactions of Restasis and Onglyza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Fall
Chronic kidney disease
Hallucination, auditory (perceiving sounds without auditory stimulus)
Joint injury
Renal injury (kidney injury)
Sedation
Somnambulism (sleep walking)
Suicide attempt
Tachyphrenia (abnormally rapid mental activity)
Aggression

60+:

Abdominal pain upper
Anxiety
Dizziness
Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Headache (pain in head)
Heart rate increased
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site haemorrhage (bleeding from injection site)
Lip oedema (swelling of lip)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 33.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 33.33%
Stress And Anxiety: 5 people, 20.83%
Multiple Allergies (allergy to multiple agents): 5 people, 20.83%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.67%
Depression: 3 people, 12.50%
Insomnia (sleeplessness): 3 people, 12.50%
Tachyphrenia (abnormally rapid mental activity): 3 people, 12.50%
High Blood Cholesterol: 3 people, 12.50%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Onglyza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously